Global API sourcing simplified
We connect API buyers and suppliers worldwide with speed, trust, and full transparency.
teaser-1024x654-1

β-Hydroxythiofentanyl API Manufacturers & Suppliers

0 verified results
When insight is your advantage
Full data, full access, full negotiation power
Total market transparency Total market transparency
|
Supplier trade data access Supplier trade data access
|
Buyer / supplier flow comparison Buyer / supplier flow comparison

Commercial-scale Suppliers

No suppliers found
Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.
Notify me!
Want to be the first to find out when a supplier for β-Hydroxythiofentanyl is listed?

Join our notification list by following this page.

List your company
Are you a supplier of β-Hydroxythiofentanyl or other APIs and are you looking to list your company on Pharmaoffer?

Click the button below to find out more

Find CDMO
Looking for a CDMO/CMO that can help you with your pharmaceutical needs?

Click the button below to switch over to the contract services area of Pharmaoffer.
When insight is your advantage
Full data, full access, full negotiation power
Total market transparency Total market transparency
|
Supplier trade data access Supplier trade data access
|
Buyer / supplier flow comparison Buyer / supplier flow comparison
Trusted by 30,000+ registered pharma professionals:
Reach multinationals, SMEs, compounding pharmacies & more!
Procaps
Pfizer
Reckitt
Sanofi
Blau
Abbvie

β-Hydroxythiofentanyl | CAS No: 1474-34-6 | GMP-certified suppliers

A medication that provides potent opioid analgesia for severe pain management, requiring careful sourcing due to regulatory restrictions and high safety and abuse risk profiles.

Generic name
β-Hydroxythiofentanyl
Molecule type
small molecule
CAS number
1474-34-6
DrugBank ID
DB09170
Approval status
Illicit drug

Product Snapshot

  • Β-Hydroxythiofentanyl is an injectable opioid small molecule formulation
  • It is primarily used for analgesic effects in pain management
  • The compound is not approved in any regulatory market and is classified as an illicit substance

Clinical Overview

β-Hydroxythiofentanyl is an opioid analgesic structurally related to fentanyl, a synthetic opioid of high potency. Chemically, it belongs to the anilide class, characterized by the presence of an amide functional group linked to an aromatic ring. Specifically, anilides are derived from oxoacids by substituting a hydroxyl group with a phenyl amino (NHPh) group or its derivatives.

This compound acts on the central nervous system, presumably engaging opioid receptors to produce analgesic effects similar to fentanyl, although detailed pharmacodynamic and mechanistic data are not formally documented in the scientific literature. Due to its structural similarity to fentanyl, β-Hydroxythiofentanyl likely exhibits strong affinity for mu-opioid receptors, resulting in potent analgesia alongside typical opioid effects such as respiratory depression, sedation, and potential for dependence.

No clinical indications have been established for β-Hydroxythiofentanyl, and the substance is primarily recognized within the context of illicit use rather than approved medical applications. Regulatory authorities do not sanction its manufacture or distribution for therapeutic purposes, reflecting concerns regarding safety and misuse.

Data regarding absorption, distribution, metabolism, and excretion (ADME) specific to β-Hydroxythiofentanyl are not available; however, as an analogue of fentanyl, it may undergo hepatic metabolism primarily via cytochrome P450 enzymes, leading to inactive metabolites excreted renally.

Safety considerations parallel those of other potent opioids, including risks of overdose, respiratory depression, and high abuse potential. The illicit status of β-Hydroxythiofentanyl complicates safety profiling and regulatory oversight.

For sourcing and quality assurance, procurement of β-Hydroxythiofentanyl APIs is subject to stringent regulatory controls due to its classification as an unapproved and controlled substance in most jurisdictions. Suppliers should ensure compliance with all applicable legal requirements and verify certificates of analysis, batch traceability, and purity standards to mitigate risks associated with illicit production and distribution.

Identification & chemistry

Generic name β-Hydroxythiofentanyl
Molecule type Small molecule
CAS 1474-34-6
UNII MG6JW60TUG
DrugBank ID DB09170

Formulation & handling

  • Β-Hydroxythiofentanyl is a small molecule suitable for oral or parenteral formulations, with limited water solubility requiring solubilizing strategies.
  • The compound's moderate lipophilicity (LogP 2.81) suggests potential for membrane permeability but also needs consideration for formulation bioavailability.
  • As an illicit anilide derivative, handling requires stringent regulatory compliance and contamination control measures during manufacturing.

Regulatory status

β-Hydroxythiofentanyl is a type of Analgesics


Analgesics are a category of pharmaceutical Active Pharmaceutical Ingredients (APIs) that are commonly used to relieve pain. They are designed to alleviate discomfort by targeting the body's pain receptors or by reducing inflammation. Analgesics are widely utilized in the medical field to manage various types of pain, ranging from mild to severe.

One of the primary classes of analgesics is nonsteroidal anti-inflammatory drugs (NSAIDs). NSAIDs work by inhibiting the production of prostaglandins, substances that contribute to pain and inflammation. This class includes well-known drugs like ibuprofen and naproxen. Another class of analgesics is opioids, which are derived from opium or synthetic compounds that mimic the effects of opium. Opioids act on the central nervous system to reduce pain perception and provide potent pain relief. Examples of opioids include morphine, codeine, and oxycodone.

Analgesics are available in various forms, such as tablets, capsules, creams, and injections, allowing for different routes of administration based on the patient's needs. They are commonly used to manage pain associated with conditions like arthritis, headaches, dental procedures, and post-operative recovery.

It is important to note that analgesics should be used under medical supervision, as improper use or overuse can lead to adverse effects, including gastrointestinal complications, addiction, and respiratory depression in the case of opioids. Therefore, it is crucial for healthcare professionals to assess each patient's individual needs and prescribe the appropriate analgesic and dosage.

In summary, analgesics are a vital category of pharmaceutical APIs used to alleviate pain by targeting pain receptors or reducing inflammation. With various classes and forms available, they provide valuable options for pain management when used responsibly and under medical guidance.